Analisa Strategi Keuangan dan Kelayakan pada Perencanaan Bisnis Laboratorium Klinik Colostat Test

Authors

  • Kawalta Tarigan Universitas Esa Unggul
  • Tantri Yanuar Rahmat Syah Universitas Esa Unggul
  • Edi Hamdi Universitas Esa Unggul
  • Muhammad Reza Hilmy Universitas Esa Unggul

DOI:

https://doi.org/10.54259/akua.v4i3.4792

Keywords:

Colorectal Cancer, ColoSTAT, Rhythm Biosciences, Internal Planning, Finance

Abstract

Colorectal cancer is a malignancy originating from the large intestine or the last small part of the large intestine before the anus. PT Mekogene Indonesia (PT MGI) business planning focuses on the innovation of a blood test-based colorectal cancer screening tool, ColoSTAT. ColoSTAT is indicated to be able to screen the risk of colorectal cancer in adult colorectal cancer suspects aged 40-85 years. Internal analysis identified ColoSTAT's competitive advantages based on simple but highly sensitive blood test technology, with strong clinical validation. This internal analysis also identified weaknesses in the form of dependence on foreign suppliers, the need for large costs for marketing, and the need to build trust in the domestic market. In terms of financial analysis with investment feasibility projections, PT MGI showed that with an initial investment of IDR 20 billion, ColoSTAT has the potential to generate positive NPV, high IRR, and attractive ROI. The financial report also estimates that breakeven can be achieved within three years through an aggressive market expansion strategy and optimal cost management. This business plan shows that PT MGI has a planned strategy to take advantage of the great opportunities in the medical device market, especially in early detection of colorectal cancer. ColoSTAT is expected to be an effective, convenient diagnostic solution that has a big impact on improving public health in Indonesia.

Downloads

Download data is not yet available.

References

R. Danu and M. Sayuti, “Manajemen Tatalaksana Kanker Kolorektal,” Detect. J. Inov. Ris. Ilmu Kesehat., vol. 1, no. 4, pp. 159–166, 2023, doi: 10.55606/detector.v1i4.2494.

Y. Xi and P. Xu, “Global colorectal cancer burden in 2020 and projections to 2040.,” Transl. Oncol., vol. 14, no. 10, p. 101174, Oct. 2021, doi: 10.1016/j.tranon.2021.101174.

E. J. Kuipers et al., “Colorectal cancer,” Nat. Rev. Dis. Prim., vol. 1, no. February 2016, pp. 1–25, 2015, doi: 10.1038/nrdp.2015.65.

H. Asmaul, Andi Kartini Eka Yanti, Arina Fathiyyah Arifin, Berry Erida Hasbi, and Dzul Ikram, “Karakteristik Penderita Kanker Kolorektal Di Rumah Sakit Pendidikan Ibnu Sina Makassar Tahun 2022,” Fakumi Med. J. J. Mhs. Kedokt., vol. 4, no. 1, pp. 19–28, 2024, doi: 10.33096/fmj.v4i1.435.

N. P. V. Primatama, A. Siswandi, T. Triwahyuni, and E. Purnanto, “GAMBARAN FAKTOR RESIKO KEJADIAN KANKER KOLOREKTAL DI RSUD Dr. H. ABDUL MOELOEK,” J. Ilmu Kedokt. dan Kesehat., vol. 10, no. 7, pp. 2461–2467, 2023, doi: 10.33024/jikk.v10i7.10808.

K. P. Pratama and A. A. Adrianto, “Faktor-Faktor Yang Mempengaruhi Kejadian Kanker Kolorektal Stadium Iii Di Rsup Dr Kariadi Semarang,” Diponegoro Med. J. (Jurnal Kedokt. Diponegoro), vol. 8, no. 2, pp. 768–784, 2019.

E. Ang, T. Jayadi, Hariatmoko, and J. W. Siagian, “Profil dan Kesintasan Penderita Kanker Kolorektal RS Bethesda Yogyakarta,” J. Kedokt. Meditek, vol. 29, no. 3, pp. 236–242, 2023, doi: 10.36452/jkdoktmeditek.v29i3.2547.

M. Sayuti and N. Nouva, “Kanker Kolorektal,” AVERROUS J. Kedokt. dan Kesehat. Malikussaleh, vol. 5, no. 2, p. 76, 2019, doi: 10.29103/averrous.v5i2.2082.

A. Kurniawan, T. Yanuar, R. Syah, D. A. Negoro, and K. Sunaryanto, “Analisa Strategi Keuangan Pada Perencanaan Bisnis Klinik Delka JURNAL MEDIA INFORMATIKA [ JUMIN ],” vol. 6, no. 2, pp. 525–532, 2024.

Downloads

Published

2025-07-10

How to Cite

Kawalta Tarigan, Tantri Yanuar Rahmat Syah, Edi Hamdi, & Muhammad Reza Hilmy. (2025). Analisa Strategi Keuangan dan Kelayakan pada Perencanaan Bisnis Laboratorium Klinik Colostat Test. AKUA: Jurnal Akuntansi Dan Keuangan, 4(3), 461–472. https://doi.org/10.54259/akua.v4i3.4792

Issue

Vol. 4 No. 3 (2025): Juli 2025

Section

Articles

License

Copyright (c) 2025 Kawalta Tarigan, Tantri Yanuar Rahmat Syah, Edi Hamdi, Muhammad Reza Hilmy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa AKUA (Jurnal Akuntansi dan Keuangan) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada AKUA (Jurnal Akuntansi dan Keuangan).